Biomarkers for assessing reproductive development and health: Part 1 - Pubertal development

Environmental Health Perspectives

Volumn 112, Issue 1, 2004, Pages 105-112

  Rockett, John C ^a   Lynch, Courtney D ^b   Buck, Germaine M ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Biomarker; Development; Human; Longitudinal cohort study; Puberty

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN; FOLLITROPIN; INHIBIN A; INHIBIN B; LEPTIN; LUTEINIZING HORMONE; MOLECULAR MARKER; MUELLERIAN INHIBITING FACTOR; SPERM ANTIBODY; TESTOSTERONE;

ADULTHOOD; BONE GROWTH; BONE MINERALIZATION; CHILD DEVELOPMENT; CHILD GROWTH; CHILD HEALTH; CONCEPTION; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC MARKER; GENETIC PREDISPOSITION; HUMAN; MALE; POPULATION EXPOSURE; PRIORITY JOURNAL; PUBERTY; REPRODUCTIVE HEALTH; RETROSPECTIVE STUDY; REVIEW;

RODENTIA;

EID: 0348129527     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.6265     Document Type: Review

References (97)

1. American Academy of Pediatrics. Pediatric Research in Office Setting. 2003. Available: http://www.aap.org/pros/ [accessed 16 May 2003].
2. Avon Longitudinal Study of Parents and Children. 2003. Available http://www.alspac.bris.ac.uk/AlspacExt/Default.shtm [accessed 10 February 2003].
3. Berg-Kelly K, Erdes L. 1997. Self-assessment of sexual maturity by mid-adolescents based on a global question. Acta Paediatr 86:10-17.
4. Boas SR, Falsetti D, Murphy TD, Orenstein DM. 1995. Validity of self-assessment of sexual maturation in adolescent male patients with cystic fibrosis. J Adolesc Health 17:42-45.
5. Bollen AM. 2000. A prospective longitudinal study of urinary excretion of a bone resorption marker in adolescents. Ann Hum Biol 27:199-211.
6. Bonat S, Pathomvanich A, Keil MF, Field AE, Yanovski JA. 2002 Self-assessment of pubertal stage in overweight children. Pediatrics 110:743-747.
7. Brann DW, Wade MF, Dhandapani KM, Mahesh VB, Buchanan CD. 2002. Leptin and reproduction. Steroids 67:95-104.
8. Brooks-Gunn J, Warren MP, Rosso J, Gargiulo J. 1987. Validity of self-report measures of girls' pubertal status. Child Dev 58829-841.
9. Brugo-Olmedo S, De Vincentiis S, Calamera JC, Urrutia F, Nodar F, Acosta AA. 2001. Serum inhibin B may be a reliable marker of the presence of testicular spermatozoa in patients with nonobstructive azoospermia. Fertil Steril 76:1124-1129.
10. Bulun SE. 2000. Aromartase deficiency and estrogen resistance: from molecular genetics to clinic. Semin Reprod 18:31-39.
11. Byrd W, Bennett MJ, Carr BR, Dong Y, Wians F, Rainey W. 1998. Regulation of biologically active dimeric inhibin A and B from infancy to adulthood in the male. J Clin Endocrinol Metab 83:2849-2854.
12. Campisi P, Tewfik TL, Manoukian JJ, Schloss MD, Pelland-Blais E, Sadeghi N. 2002. Computer-assisted voice analysis. Arch Otolaryngol Head Neck Surg 128:156-160.
13. Carskadon MA, Acebo C. 1993. A self-administered rating scale for pubertal development. J Adolesc Health 14:190-195.
14. Check JH, Check ML, Katsoff D. 2002. Prognosis for sperm fertilizability: analysis of different variables in men. Arch Androl 48:73-83.
15. Chen W, Sheets J, Nolan R, Mattsson J. 1999. Human red blood cell acetylcholinesterase inhibition as the appropriate and conservative surrogate endpoint for establishing chlorpyrifos reference dose. Regul Toxicol Pharmacol 29:15-22.
16. Cocco S, Meloni A, Marini MG, Can A, Moi P. 1996. A missense (T577I) mutation in the luteinizing hormone receptor gene associated with familial male-limited precocious puberty. Hum Mutat 7:164-166.
17. Crofton PM, Evans AE, Groome NP, Taylor MR, Holland CV, Kelnar CJ. 2002. Inhibin B in boys from firth to adulthood: relationship with age, pubertal stage, FSH and testosterone. Clin Endocrinol (Oxf) 56:215-221.
18. Crofton PM, Wade JC, Taylor MR, Holland CV. 1997. Serum concentrations of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxyl-terminal telopeptide of type I collagen, and their interrelationships in schoolchildren. Clin Chem 43:1577-1581.
19. Delemarre-van de Waal HA. 2002. Regulation of puberty. Best Pract Res Clin Endocrinol Metab 16:1-12.
20. de Muinich Keizer SM, Mul D. 2001. Trends in pubertal development in Europe. Hum Reprod Update 7:287-291.
21. Domenico S, Latronico AC, Brito VN, Arnhold IJ, Kok F, Mendonca BB. 2001. Adrenocorticotropin-dependent precocious puberty of testicular origin in a boy with X-linked adrenal hypoplasia congenita due to a novel mutation in the DAX1 gene. J Clin Endocrinol Metab 86:4068-4071.
22. Duke PM, Litt IF, Gross RT. 1980. Adolescents' self-assessment of sexual maturation. Pediatrics 66:918-920.
23. Family Practice Notebook.com. 2003a. Male Tanner Stage. Available: http://www.fpnotebook.com/END30.htm [accessed 28 May 2003].
24. Family Practice Notebook.com. 2003b. Female Tanner Stage. Available: http://www.fpnotebook.com/END31.htm [accessed 28 May 2003].
25. Foster CM, Phillips DJ, Wyman T, Evans LW, Groome NP, Padmanabhan V. 2000. Changes in serum inhibin, activin and follistatin concentrations during puberty in girls. Hum Reprod 15:1052-1057.
26. Freedman DS, Khan LK, Serdula MK, Srinivasan SR, Berenson GS. 2000. Secular trends in height among children during 2 decades: The Bogalusa Heart Study. Arch Pediatr Adolesc Med 154:155-161.
27. Golding J, Pembrey M, Jones R. 2001. ALSPAC - the Avon Longitudinal Study of Parents and Children. I. Study methodology. Paediatr Perinat Epidemiol 15:74-87.
28. Hardoff D, Tamir A. 1993. Self-assessment of pubertal maturation in socially disadvantaged learning-disabled adolescents. J Adolesc Health 14:398-400.
29. Harries MLL, Walker JM, William DM, Hawkins S, Hughes IA. 1997. Changes in the male voice at puberty. Arch Dis Child 1997:445-447.
30. Healthchecksystems.com. 2003. Available: http://www.healthchecksystems.com/bodyfatmeasure.htm [accessed 10 February 2003].
31. Hecht SS. 2002. Human urinary carcinogen metabolites: biomarker for investigating tobacco and cancer. Carcinogenesis 23:907-922.
32. Hergenroeder AC, Hill RB, Wong WW, Sangi-Haghpeykar H, Taylor W. 1999. Validity of self-assessment of pubertal maturation in African American and European American adolescents. J Adolesc Health 24:201-205.
33. Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ, Bhapkar MV, Koch GG, et al. 1997. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics 99:505-512.
34. Herman-Giddens ME, Wang L, Koch G. 2001. Secondary sexual characteristics in boys: estimates from the National Health and Nutrition Examination Survey III, 1988-1994. Arch Pediatr Adolesc Med 155:1022-1028.
35. Hick KM, Katzman DK. 1999, Self-assessment of sexual maturation in adolescent females with anorexia nervosa. J Adolesc Health 24:206-211.
36. Hudson PL, Dougas I, Donahoe PK, Cate RL, Epstein J, Popinsky RB, et al. 1990. An immunoassay to detect human mullerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab 70:16-22.
37. Iatropoulos MJ, Williams GM. 1996. Proliferation markers. Exp Toxicol Pathol 48:175-181.
38. Karlberg J. 2002. Secular trends in pubertal development. Horm Res 57(suppl 2):19-30.
39. Karpati AM, Rubin CH, Kieszak SM, Marcus M, Troiano RP. 2002. Stature and pubertal stage assessment in American boys: the 1988-1994 Third National Health and Nutrition Examination Survey. J Adolesc Health 30:205-212.
40. Krstevska-Konstantinova M, Charlier C, Craen M, Du Caju M, Heinrichs C, de Beaufort C, et al. 2001. Sexual precocity after immigration from developing countries to Belgium: evidence of previous exposure to organochlorine pesticides. Hum Reprod 16:1020-1026.
41. Kurpisz M, Kasprzak M, Mazurkievvicz I. 1996. The easy formation of antisperm antibodies in prepubertal boys and the difficult humoral response in severe-combined immunodeficiency mice. Fertil Steril 66:805-808.
42. Lasley BL, Mobed K, Gold EB. 1994. The use of urinary hormonal assessments in human studies. Ann NY Acad Sci 709:299-311.
43. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, et al. 1996. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 81:571-576.
44. Lenzi A, Gandini L, Lombardo F, Cappa M, Nardini P, Ferro F, et al. 1991. Antisperm antibodies in young boys. Andrologia 23:233-235.
45. Lindgren G. 1996. Pubertal stages 1980 of Stockholm schoolchildren. Acta Paediatr 85:1365-1367.
46. Lucas JN. 1997. Chromosome translocations: a biomarker for retrospective biodosimetry. Environ Health Perspect 105(suppl 6):1433-1436.
47. Lum A, Le Marchand L. 1998. A simple mouthwash method for obtaining genomic DNA in molecular epidemiological studies. Cancer Epidemiol Biomarkers Prev 7:719-724.
48. MacGillivray MH, Morishima A, Conte F, Grumbach M, Smith EP. 1998. Pediatric endocrinology update: an overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover: lessons from mutations in the genes for aromatase and the estrogen receptor. Horm Res 49(S1):2-8.
49. Mantzoros CS, Flier JS, Fogel AD. 1997. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab 82:1066-1070.
50. Marui S, Castro M, Latronico AC, Elias LL, Arnhold J, Moreira AC, et al. 2000. Mutations in the type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls. Chin Endocrinol (Oxf) 52:67-75.
51. Marshall WA, Tanner JM. 1969. Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291-303.
52. Marshall WA, Tanner JM. 1970. Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13-23.
53. Minnesota Children's Pesticide Exposure Study. 1997-Present. Available: http://www.health.state.mn.us/divs/eh/children/ exposurestudy.html [accessed 10 February 2003].
54. Mol NM, Sorensen N, Weihe P, Andersson AM, Jorgensen N, Skakkebaek NE, et al. 2002. Spermaturia and serum hormone concentrations at the age of puberty in boys prenatally exposed to polychlorinated biphenyls. Eur J Endocrinol 146:357-363.
55. Morris NM, Udry JR. 1980. Validation of a self-assessment instrument to assess stage of adolescent development. J Youth Adolesc 9:271-280.
56. National Children's Study. 2003. Available: http://nationalchildrensstudy.gov [accessed 10 February 2003].
57. National Health and Nutrition Examination Survey. 2003. Available: http://www.cdc.gov/nchs/nhanes.htm [accessed 16 May 2003]
58. Neinstein LS. 1982. Adolescent self-assessment of sexual maturation: reassessment and evaluation in a mixed ethnic urban population. Clin Pediatr (Phila) 21:482-484.
59. Northern California Childhood Leukemia Study, 1995-2003. 2003. National Institute of Environmental Health Sciences and National Cancer Institute. Available: http://www.clinicaltrials.gov/ct/gui/show/NCT00015587?order=19 [accessed 10 February 2003].
60. Nysom K, Pedersen JL, Jorgensen M, Nielsen CT, Muller J, Keiding N, et al. 1994. Spermaturia in two normal boys without other signs of puberty. Acta Paediatr 83:520-521.
61. Padez C. 2002. Stature and stature distribution in Portuguese male adults 1904-1998: the role of environmental factors. Am J Human Biol 14:39-49.
62. Papadimitriou A. 2001. Sex differences in the secular changes in pubertal maturation. Pediatrics 108:E65.
63. Petersen AC, Crockett L, Richards M, Boxer A. 1988. A self-report measure of pubertal status: reliability, validity, and initial norms. J Youth Adolesc 17:117-133.
64. Poirier MC, Weston A. 1996. Human DNA adduct measurements: state of the art. Environ Health Perspect 104(suppl 5):883-893.
65. Raivio T, Dunkel L. 2002. Inhibins in childhood and puberty. Best Pract Res Clin Endocrinol Metab 16:43-52.
66. Rajpert-De Meyts E, Jorgensen N, Graem N, Muller J, Cate RL, Skakkebaek NE. 1999. Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 84:3836-3844.
67. Redding TW, Kastin AJ, Gonzales-Barcena D, Coy DH, Coy EJ, Schalch DS, et al. 1973a. The half-life, metabolism and excretion of tritiated luteinizing hormone-releasing hormone (LH-RH) in man. J Clin Endocrinol Metab 37:626-631.
68. 3H-labeled L-prolyl-L-leucyl-glycinamide in the rat. Neuroendocrinology 11:92-100.
69. Reddy VR, Gupta SM, Meherji PK. 2001. Expression of integrin receptors on peripheral lymphocytes: correlation with endometrial receptivity. Am J Reprod Immumol 46:188-195.
70. Riggins GJ. 2001. Using Serial Analysis of Gene Expression to identify tumor markers and antigens. Dis Markers 17:41-48.
71. Rockett JC. 2002. Surrogate tissue analysis for monitoring the degree and impact of exposures in agricultural workers. AgBiotechNet 4, ABN 100.
72. Rockett JC, Buck GM, Lynch CD, Perreault SD. 2004. The value of home-based collection of biospecimens in reproductive epidemiology. Environ Health Perspect 112:94-104.
73. Rockett JC, Kavlock RJ, Lambright CR, Parks LG, Schmid JE, Wilson VS, et al. 2002. DNA arrays to monitor gene expression in rat blood and uterus following 17beta-estradiol exposure: biomonitoring environmental effects using surrogate tissues. Toxicol Sci 69:49-59.
74. Roemmich JN, Rogol AD. 1999. Role of leptin during childhood growth and development. Endocrinol Metab Chin North Am 28:749-64, viii.
75. Saetung S, Kosulwat V, Charoenkiatkul S, Suthutvoravut U, Komindr S, Rajroongwasinkul N. 2000. Body fat and lean body mass estimated from dual energy X-ray absorptiometry, anthropometry and bioelectrical impedance analysis in Thai children. Mahidol University Annual Research Abstracts. Available:http://www.mahidol.ac.th/abstracts/annual1999/0635.htm [accessed 24 December2002].
76. Samaha HS, Kelloff GJ, Steele V, Rao CV, Reddy BS. 1997. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res 57:1301-1305.
77. Samaras TT, Storms LH. 2002. Secular growth and its harmful ramifications. Med Hypotheses 58:93-112.
78. Schall JI, Semeao EJ, Stallings VA, Zemel BS. 2002. Self-assessment of sexual maturity status in children with Crohn's disease, J Pediatr 141:223-229.
79. Schlossberger NM, Turner RA, Irwin CE J. 1992. Validity of self-report of pubertal maturation in early adolescents. J Adolesc Health 13:109-113.
80. Schoket B, Poirier MC, Mayer G, Torok G, Kolozsi-Ringelhann A, Bognar G, et al. 1999. Biomonitoring of human genotoxicity induced by complex occupational exposures. Mutat Res 445:193-203.
81. Sehested A, Juul AA, Andersson AM, Petersen JH, Jensen TK, Muller J, et al. 2000. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels. J Clin Endocrinol Metab 85:1634-1640.
82. Selevan SG, Rice DC, Hogan KA, Euling SY, Pfahles-Hutchens A, Bethel J. 2003. Blood lead concentration and delayed puberty in girls. N Engl J Med 348:1527-1536.
83. Sen AT, Derman O, Kinik E. 2000. The relationship between osteocalcin levels and sexual stages of puberty in male children. Turk J Pediatr. 42:281-285.
84. Sinisi AA, D'Apuzzo A, Pasquali D, Venditto T, Esposito D, Pisano G, et al. 1997. Antisperm antibodies in prepubertal boys treated with chemotherapy for malignant or non-malignant diseases and in boys with genital tract abnormalities. Int J Androl 20:23-28.
85. Stratakis CA, Vottero A, Brodie A, Kirschner LS, DeAtkine D, Lu Q, et al. 1998. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. J Clin Endocrinol Metab 83:1348-1357.
86. Tanner JM. 1962. Growth at Adolescence. Oxford: Blackwell.
87. Tanner JM. 1986. Normal growth and techniques of growth assessment. Clin Endocrinol Metab 15:411-451.
88. Teilmann G, Juul A, Skakkebaek NE, Toppari J. 2002. Putative effects of endocrine disrupters on pubertal development in the human. Best Pract Res Clin Endocrinol Metab 16:105-121.
89. Thomas RS, Rank DR, Penn SG, Zastrow GM, Hayes KR, Pande K, et al. 2001. Identification of toxicologically predictive gene sets using cDNA microarrays. Mol Pharmacol 60:1189-1194.
90. U.S.-Mexico Border XXI Environmental Health Workgroup, 1996-2004. 2003. Pesticide Exposure and Potential Health Effects in Young Children Along The U.S.- Mexico Border. U.S. Environmental Protection Agency. Available: http://www.epa.gov/orsearth/pesticide5_13.htm [accessed 10 February 2003].
91. van Coeverden SC, Netelenbos JC, de Ridder CM, Roos JC, Popp-Snijders C, Delemarre-van de Waal HA. 2002. Bone metabolism markers and bone mass in healthy pubertal boys and girls. Clin Endocrinol (Oxf) 57:107-116.
92. Wang EY, Draper LB, Lee E, Polak A, Sluss P, Weiss J, et al. 1999. Identification of naturally occurring follistatin complexes in human biological fluids. Biol Reprod 60:8-13.
93. Williams RL, Cheyne KL, Houtkooper LK, Lohman TG. 1988. Adolescent self-assessment of sexual maturation. J Adolesc Health Care 9:480-482.
94. Witchel SF, Smith R, Tomboc M, Aston CE. 2001. Candidate gene analysis in premature pubarche and adolescent hyperandrogenism. Fertil Steril 75:724-730.
95. Wu FC, Brown DC, Butler GE, Stirling HF, Kelnar CJ. 1993. Early morning plasma testosterone is an accurate predictor of imminent pubertal development in prepubertal boys. J Clin Endocrinol Metab 76:26-31.
96. Wu T, Buck GM, Mandela P. 2003. Blood lead levels and sexual maturation in U.S. Girls: The Third National Health and Nutrition Examination Survey, 1988-94. Environ Health Perspect 111:737-741.
97. Wu T, Mendola P, Buck GM. 2002. Ethnic differences in the presence of secondary sex characteristics and menarche among US girls: the Third National Health and Nutrition Examination Survey, 1988-1994. Pediatrics 110:752-757.